3-chloro-4-hexyloxy-benzaldehyde 、 肼甲酰亚胺酰胺一氯化氢 以to give the title compound (2047) as a white powder (141 mg, 49%)的产率得到1-(3-Chloro-4-hexyloxybenzylideneamino)guanidine Hydrochloride
参考文献:
名称:
Treating neuropathic pain with neuropeptide FF receptor 2 agonists
TREATING NEUROPATHIC PAIN WITH NEUROPEPTIDE FF RECEPTOR 2 AGONISTS
申请人:Acadia Pharmaceuticals Inc.
公开号:EP1687641A2
公开(公告)日:2006-08-09
[EN] TREATING NEUROPATHIC PAIN WITH NEUROPEPTIDE FF RECEPTOR 2 AGONISTS<br/>[FR] TRAITEMENT DE LA DOULEUR NEUROPATHIQUE AVEC DES AGONISTES DU RECEPTEUR 2 DU NEUROPEPTIDE FF
申请人:ACADIA PHARM INC
公开号:WO2005031000A2
公开(公告)日:2005-04-07
The invention described below relates to the discovery of the neuropeptide FF receptor subtype that mediates acute nociception and chronic neuropathic pain, compounds that selectively interact with this receptor subtype and methods for treating acute pain and chronic neuropathic pain.
[EN] CELL IMPERMEABLE COELENTERAZINE ANALOGUES<br/>[FR] ANALOGUES DE COELENTÉRAZINE IMPERMÉABLES AUX CELLULES
申请人:PROMEGA CORP
公开号:WO2018102693A1
公开(公告)日:2018-06-07
Described are coelenterazine analogues, methods for making the analogues, kits comprising the analogues, and methods of using the compounds for the detection of luminescence in luciferase-based assays.